reSee.it - Related Video Feed

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. There is a push to recommend Ozempic for Americans as young as six for obesity, a condition claimed to be preventable. It is claimed that if 74% of Americans took Ozempic, the cost would be $3 trillion a year. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. It is claimed that for half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. It is claimed that members of Congress are doing the bidding of Novo Nordisk instead of standing up for American farmers and children because Novo Nordisk is one of the largest funders of medical research.

Big Food is secretly trying to hack Ozempic with the help of a food laboratory called Matson, run by Justin Shimick. Matson is reformulating ingredients to bypass the effects of GLP-1 weight loss drugs because these drugs are cutting into food company profits. Walmart's CEO has noticed that people on these medications are buying less food. Food companies are designing "GLP-1 optimized products" to make food even more addictive by using tactics like nostalgic aromas, amplified artificial sweeteners, and altered salt crystals. This is all being done in secret as Justin Shimick wouldn't disclose which companies he's working with, stating that they are "professional secret keepers". The end result could be that obesity persists, drugs with side effects become ineffective, and it's all shrouded in secrecy.

The speaker discusses GLP-1 hormones and GLP-1 drugs, naming Ozempic and its sister drug Wegovy, made by Novo Nordisk in Denmark. The speaker says Novo Nordisk has made “two point two one trillion dollars” on Ozempic and Wegovy and that America buys “ninety percent of it,” attributing this to being “the most overweight.” The speaker claims that “there’s no GLP-1 anything in Ozempic or Wegovy,” and says the only substance inside is “Exendin-4” (spelled “E X E N D I N dash four”). The speaker states that Exendin-4 is a protein isolated from the venom of a Gila monster lizard living in the southwestern United States deserts, and that venom protein research on the Gila monster began in 1956, referencing a medical textbook titled “Venoms” from 1956. The speaker says the Gila monster venom protein paralyzes the vagal nerve and “paralyz[es] the stomach sphincter” that empties food into the intestines. The speaker claims this makes people “not be hungry for hours” because food “isn’t going into your intestines to be broken down,” and therefore isn’t turned into fecal matter and nutrients for absorption into the bloodstream. The speaker further claims that because people self-inject Ozempic or Wegovy once a week for the rest of their lives, Exendin-4 circulates through the bloodstream and “touch[es]” L-cells, which release GLP-1 hormone. The speaker claims that the toxicity of Gila monster venom has been discussed in media as being “as toxic and deadly as” western diamondback rattlesnake venom, and asserts that millions of Americans are injecting it. The speaker also says Exendin-4 has an FDA “black box warning” stating that self-injecting for twelve to thirty-six months “trip[les] your risk of developing thyroid cancer,” specifically “medullary thyroid cancers,” and that “there are multiple of them.” The speaker says oncologists reported not seeing thyroid cancers “exploding” in Ozempic and Wegovy users, but instead reported “explosions of breast cancer diagnosis” within a year or two after starting. The speaker also claims Exendin-4 is published to cause “nerve growth factor and epidermal growth factor,” described as cancer-related terms for tumor growth in the brain and organs. The speaker further claims that “one in five” will develop “diabetic ret-retinopathy,” causing permanent blindness, and references a People magazine article titled “People on Ozempic are now reporting eye rotting disease.” The speaker says venom “destroys human tissue” and calls Ozempic and Wegovy “venom,” not a cure. The speaker asks people who are losing weight whether they believe they were overweight, diabetic, and had heart disease due to “Hela monster venom deficient,” and asks why they would inject it if they do not believe that. The speaker says medical doctors are unaware of this and describes sending research and mainstream articles; the speaker claims doctors responded in unison that they would not prescribe it again and that they would tell their patients to stop.

Fifteen percent of high schoolers are on Adderall, which was created by Merck in Nazi Germany to make German soldiers more aggressive. The drug was discontinued due to psychosis among soldiers, but Merck reformulated it into a stronger version, which is now Adderall. Parents are being pressured to put their kids on Adderall, just as they are with Ozempic, SSRIs, and SANs. Children in sedentary environments with limited sunlight, being fed ultra-processed food, are prescribed Adderall for being fidgety. This is mass child abuse, and it is being normalized.

Novo Nordisk has faced accusations of shady sales tactics, including spending heavily on doctors, and has encountered regulatory issues in multiple countries. The company, along with other drug makers, has been criticized for high insulin prices. While insulin profits have decreased, weight loss drugs offer astronomical profit potential, which Novo Nordisk is already capitalizing on. The company's valuation once exceeded Denmark's entire GDP. Some individuals, distrustful of big pharma or lacking access to these drugs, are seeking alternatives.

Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Speaker 0 argues that history will view this presidency as probably the most reckless and corrupt in the history of the United States, and expresses fear that without change the country and the world risk major harm, including the possibility of World War III. They say, regardless of views on global leadership, that being on top “what good is it … if you've created an absolute hellscape?” They emphasize the need for the course to change and suggest the future of the United States as a cohesive country and the world is currently in question because of the administration’s behavior. Speaker 1 agrees that America used to hold the moral high ground—defending human rights, free speech, and free trade—but asserts that none of those things are true any longer. They claim America is “the terror regime of the world,” describing it as pillaging, stealing, bombing, assassinating, running color revolutions, lying, and doing everything possible to destroy others to keep America as the last nation standing on its pile of soon to be worthless debt. They state this is not a moral position from which to lead any civilization. Speaker 0 contends that America has the tools to be all those values, citing a great constitutional republican system, the federation of states, resources, and human capital. They note a problem, however: a “giant pile of worthless fiat paper,” with the bill coming due and the tantrums of an empire, referencing warnings by people like Gerald Celente and Alex Jones about a fiat bubble rupture. They say the question is where the country wants to be in the world, criticizing a lack of imagination among the “great and the good in America” about a compelling future. Speaker 1 adds a new issue: 31 million Americans are injecting themselves with GLP-1 drugs, which they say cause a 100% increase in risk of psychiatric disorders and suicidal ideation, especially among women, with the most use among 50–65-year-olds. They claim Trump is working to make these drugs more affordable so that more people can take them, potentially leading to half of US adults using a drug based on venom peptides of the Gila monster, a paralyzing agent, risking madness. They compare this to lead poisoning and reference Ozempic as one of these drugs. Speaker 0 asks, “What’s it called? Ozempic? Is that a GOP one?” Speaker 1 confirms “Ozempic,” and notes that the drugs are used for vanity to look healthy, not because people are actually healthy. They reiterate the core issue: what goes into bodies and the environment in which people live, stressing that there is an opportunity today to correct and improve the situation, and that many are taking that opportunity.

Ozempic breaks people's bones. Pharmaceutical companies selling weight loss pills have side effects that include breaking people's bones. Instead of cleaning up their diet, eating organic, working out, getting rid of Wi Fi, and spending time in nature, people are going to pharmaceutical companies expecting results. When your bones break in half, it doesn't matter if you lose weight. Taking care of yourself and being healthy takes work. If you're concerned about weight loss, you should be concerned about what's in your house, what you're eating, the chemicals you're spraying all over your body, and the lotions you're putting all over your head. If you can't lose weight, it's probably your diet, and an all-organic diet can heal everything. Pharmaceutical companies poison people to gain weight, then sell them something to make them lose weight, which causes their bones to break, creating patients for life.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 monthly, with most having received money from Novo Nordisk, its manufacturer. Approval for Medicare would extend to Medicaid, with potential recommendations for Americans as young as six for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the total cost of Ozempic prescriptions could reach $3 trillion annually. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. The company's value relies on projected Ozempic sales in America. For half the cost of Ozempic, every American could receive regeneratively raised organic food and obese Americans could receive gym memberships. The speaker questions why Congress is supporting Novo Nordisk over American farmers and children, suggesting Novo Nordisk's funding of medical research influences media, politicians, and medical schools.

Ozempic carries a black box warning for increasing the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. Thousands of Americans are reporting eye-rotting diseases from using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. According to the Smithsonian Institute, Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease due to a Gila monster venom deficiency.

Novo Nordisk, the pharmaceutical company behind the weight loss drug Ozempic, is debunking conspiracy theories about profiting off people's health issues. They are lobbying the government to support the Treat and Reduce Obesity Act of 2023, which allows coverage for obesity treatment under Medicare. The company's stock has seen significant growth, and they have spent millions on lobbying and stock buybacks. While some board members have connections to other companies, Novo Nordisk aims to improve people's health. Critics argue that the drug has side effects and is expensive, but an article by Yoni Friedhoff, who received grants from Novo Nordisk, refutes these claims. Trusting the science and pharmaceutical companies is important for better health.

Medicine is important for specific treatments, but primary care should emphasize lifestyle changes before prescribing medication. It's easier to prescribe drugs like omeprazole than to advise weight loss and dietary changes, but these medications can cause problems like osteoporosis or C. Diff. Overweight patients often need higher doses of medication, but weight loss should be the first step. Doctors may over-prescribe medication to allow patients to continue unhealthy habits, like eating steak. Instead, people should balance indulgences with healthier choices. Doctors may favor drugs like Ozempic because they offer a quick solution when lifestyle changes seem improbable. Insurance may cover weight loss medication but offer limited support for nutritionists. There should be incentives in the workplace to encourage exercise.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. Once approved for Medicare, the drug will likely extend to Medicaid, with recommendations for use in children as young as 6 for obesity, a largely preventable condition. With 74% of Americans classified as obese, the potential annual cost for Ozempic prescriptions could reach $3 trillion. While Novo Nordisk thrives on these projections, the Danish government advocates for dietary changes and exercise instead. For the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk in medical research funding raises concerns about Congress prioritizing corporate interests over American health and agriculture.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

Over a hundred members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its manufacturer. Once Medicare approves, Medicaid follows. There's a push to prescribe Ozempic for obesity in Americans as young as six, a condition largely preventable. With 74% of Americans obese, covering Ozempic prescriptions would cost $3 trillion annually. Novo Nordisk's value relies heavily on projected Ozempic sales in the US, yet Denmark, their home country, favors diet and exercise over the drug. For half the cost of Ozempic, we could provide regeneratively raised organic food to every American, three times a day, and gym memberships for every obese American. Why is Congress prioritizing this company over American well-being? I've dedicated my life to solving the childhood chronic disease crisis, and I see an opportunity for bipartisan change to improve American health, our economy, and our nation's spirit.

The discussion centers on NASA funding of Redwire, a company formed in 2020 through the combination of ad-col space and deep space systems, which expanded by absorbing Made in Space and grew from space infrastructure into capabilities spanning spacecraft components, deployable structures, robotic manufacturing, mission systems, and space research platforms. By 2025, Redwire described itself as an integrated space and defense tech company emphasizing multi-domain operations, autonomous systems, AI-enabled platforms, and defense contracts. It completed the acquisition of Edge Autonomy and began delivering drone systems connected to U.S. and allied defense programs, including support tied to the U.S. Army and NATO. Redwire’s public identity is framed around convergence of space systems, airborne platforms, autonomy, and warfighting capabilities. A key claim is that Redwire has launched a pharmaceutical venture called SpaceMD, announced in August 2025, described as commercializing pharmaceutical development in space by growing seed crystals in microgravity for use in new or reformulated drugs. The effort is said to be built around Pillbox, short for Pharmaceutical In-Space Laboratory. Pillbox is described as an orbital pharmaceutical platform that Redwire says has flown repeatedly to the International Space Station, with 28 Pillbox systems having flown in space and 17 crystallized compounds already produced on the International Space Station as of the SpaceMD launch announcement, including insulin and other critical molecules. In March 2026, NASA awarded Redwire an additional $4 million to continue drug development in microgravity using Pillbox, under a contract with a ceiling of up to $25 million over five years. SpaceMD is described by Redwire’s CEO Peter Canito as a wholly owned subsidiary focused exclusively on commercialization of Redwire’s proven on-orbit drug manufacturing capability. He explains that crystals of molecules are used to study efficacy, delivery methods, and molecular attributes, and that Pillbox takes molecules into space to grow their crystals. The conversation then questions why NASA would fund this approach. A senior health advisor, Ellie Hirsch, says public money is being used to help powerful corporations move drug development into a domain where oversight is weaker, control is tighter, and the public has even less say, and argues that moving drug development into space makes it harder for the public to question, verify, and fully understand what is being created. Hirsch also highlights perceived risks from vaccines and other pharmaceuticals created on Earth and argues that transparency and long-term monitoring should not be optional when deploying medical policies. They discuss potential jurisdiction and oversight issues tied to International Space Station operations and frame concerns about accountability if things go wrong. Hirsch also describes Pillbox-related “crystals” as laying “foundation” for vaccines and claims that past mRNA vaccine effects are still being seen, with severe side effects experienced by people. A separate segment describes Juanita Gant, who struggled with weight and at age 62 was prescribed Wegovy and later Ozempic, both GLP-1 drugs made by Novo Nordisk. In October 2023, she was found unconscious, and doctors found parts of her large intestine had died and it had to be removed; she later went into cardiac arrest. She is said to be suing Novo Nordisk for allegedly inadequate label warnings about potentially serious side effects, including gastroparesis (stomach paralysis) and bowel obstruction. The advisor and host also contrast pharmaceuticals with natural approaches and discuss immune system concepts centered on T cells, describing killer T cells, helper T cells, regulatory T cells, and memory T cells. Hirsch claims T cells defend against pathogens and also against dangers of synthetic health threats and frames fermented foods as supporting immune function. She emphasizes kimchi as “king of fermented foods,” claiming kimchi improves microbial diversity, cites a comparison of “over 900 strains” in kimchi versus “28 strains” in sauerkraut, and asserts research shows kimchi reduces obesity by 31.8%. Hirsch argues that pharmaceuticals should be a last resort rather than a first resort and claims kimchi—requiring daily consumption—can help balance the gut microbiome and reduce inflammation-related issues such as brain fog and chronic fatigue.

Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

Ozempic causes appetite suppression, leading to weight loss, but also nausea and vomiting, causing some to stop usage. While effective and offering metabolic benefits from weight loss, it's very expensive, costing $1,300-$1,700 monthly. Weight returns upon cessation without lifestyle changes; it doesn't address behavior or habits. A significant downside is muscle loss, with 50% of weight lost being muscle, which is crucial for metabolism and overall health. Counteracting this requires increased protein intake and weight training. Metabolism may be slower post-treatment due to muscle loss. Long-term side effects are emerging, including a 450% increase in bowel obstruction and a 900% increase in pancreatitis. The drug addresses a symptom, not the cause, which is a toxic environment, lifestyle, and food system. Addressing obesity requires policy changes, agricultural and food system reform, and widespread education, which faces resistance from the large food industry.

Ozempic carries a black box warning that it increases the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. People magazine reported thousands of Americans are experiencing eye-rotting diseases while using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. The Smithsonian Institute told CNN that Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease because they are Gila monster venom deficient.

Ozempic, a diabetes drug that aids weight loss, is gaining popularity despite concerns. Cali Means highlights three major issues: first, obesity is a symptom of deeper metabolic dysfunction, not a deficiency treatable by medication. Second, the drug has significant side effects, including gastrointestinal issues and potential mental health risks, with many users discontinuing it within months. Third, systemic corruption in healthcare, where pharmaceutical companies influence medical guidelines and funding, exacerbates the problem. Instead of addressing root causes like diet and lifestyle, the focus remains on lifelong drug dependency. Means advocates for a shift towards preventive measures, emphasizing better nutrition and exercise as essential for improving public health. He believes that reforming healthcare practices and policies can reverse the current metabolic health crisis.